What would be an expected outcome after administered medication to promote clotting?

The selection of increased clotting factor production as the expected outcome after administering medication designed to promote clotting is accurate. Medications that encourage clotting, such as certain clotting factor concentrates or synthetic agents, typically aim to increase the presence of clotting factors in the bloodstream. These factors are essential for effective blood coagulation, allowing for the formation of blood clots to prevent excessive bleeding.

In individuals who have deficiencies in specific clotting factors, such as those with hemophilia, the administration of these medications aids in correcting the underlying issue, thereby enhancing their ability to form clots. This can lead to a more stable hemostatic response during situations where clotting is necessary, such as after injury or surgery.

The other outcomes listed are not consistent with the purpose of medications that promote clotting. For instance, increased bruising would generally indicate that there is a problem with coagulation or that excessive anticoagulation is taking place. A normal bleeding time would suggest that clotting is functioning properly without the need for further intervention. Decreased blood viscosity is unrelated to the primary action of promoting clot formation; medications affecting viscosity typically focus on overall blood flow dynamics rather than clot formation itself. Thus, increased clotting factor production aligns directly with the goal